Response Genetics, Inc. Stock Nasdaq
Equities
US76123U1051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Response Genetics, Inc Bankruptcy Case Dismissed | CI |
2016 | Motion for Case Dismissal Filed for Response Genetics, Inc | CI |
Financials (USD)
Sales 2013 | 19.8M | Sales 2014 | 16.72M | Capitalization | 12.28M |
---|---|---|---|---|---|
Net income 2013 | -8M | Net income 2014 | -13M | EV / Sales 2013 | 1.92 x |
Net cash position 2013 | 6.85M | Net Debt 2014 | 7.45M | EV / Sales 2014 | 1.18 x |
P/E ratio 2013 |
-4.84
x | P/E ratio 2014 |
-0.9
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Roy Harris
DFI | Director of Finance/CFO | 55 | 12-08-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Roy Harris
DFI | Director of Finance/CFO | 55 | 12-08-19 |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |